Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.

Also called NCT02378883

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 112 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02378883
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02378883. Allocation not applicable; no masking; primary purpose treatment. Start 2015-05-18 (actual); primary completion 2018-02-20 (actual). Results posted on 2019-04-29.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study
Condition
Arteriovenous Malformations
Intervention (Device)
Apollo™ Onyx™ Delivery Micro Catheter
Lead sponsor
Medtronic Neurovascular Clinical Affairs (class: industry)

Record details

Record id
cardio:ct-nct02378883
Content hash
b55e5159be0bb7c78d2c2bdaa54eeae927abc1b429080af6ddfe6d54c616795d